Group 1 - GSK has entered into an agreement to acquire Canada's 35Pharma, aiming to enhance its portfolio in diseases associated with obesity [1]

GSK to buy 35Pharma for $950 million | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration [Purchase Licensing Rights, opens new tab]- Companies[GSK plc]FollowFeb 25 (Reuters) - GSK [(GSK.L), opens new tab] on Wednesday agreed to buy Canadian biopharmaceutical company 35Pharma Inc for $950 million in cash.Sign up [here.]Reporting by ...

Group 1 - Frontier Biotechnologies has entered into a deal with GSK, granting GSK worldwide rights to develop two small interfering RNA therapies targeting kidney diseases [1] - The agreement could be worth up to $1 billion, indicating significant potential for both companies in the biopharmaceutical market [1] - This collaboration highlights the growing interest and investment in RNA-based therapies within the healthcare and pharmaceutical industry [1]

Summit Therapeutics (NasdaqGM:SMMT) Q4 2025 Earnings call February 23, 2026 04:30 PM ET Company ParticipantsAllen Yang - Chief R&D Strategy OfficerDave Gancarz - Chief Business and Strategy OfficerJosh Schimmer - Senior Managing Director and Leader in Biotechnology Equity ResearchMaky Zanganeh - Co-CEO and PresidentManmeet S. Soni - COO and CFOMark Schwartz - Vice ChairmanRobert Duggan - Co-Chief Executive Officer and Chairman of the BoardConference Call ParticipantsAsthika Goonewardene - Managing Director ...

Summit Therapeutics (NasdaqGM:SMMT) Q4 2025 Earnings call February 23, 2026 04:30 PM ET Company ParticipantsAllen Yang - Chief R&D Strategy OfficerDave Gancarz - Chief Business and Strategy OfficerJosh Schimmer - Senior Managing Director and Leader in Biotechnology Equity ResearchMaky Zanganeh - Co-CEO and PresidentManmeet S. Soni - COO and CFOMark Schwartz - Vice ChairmanRobert Duggan - Co-Chief Executive Officer and Chairman of the BoardConference Call ParticipantsAsthika Goonewardene - Managing Director ...

Summit Therapeutics (NasdaqGM:SMMT) Q4 2025 Earnings call February 23, 2026 04:30 PM ET Speaker10Good afternoon, welcome to Summit, Summit Therapeutics Q4 and year-end 2025 earnings call. All participants will be in listen-only mode until the question and answer session portion of this call. We do not expect any technical difficulties today. However, in the event that we lose the webcast connection and are unable to provide any updates, please wait up to 10 minutes for resolution. Please refer to the compan ...

Summit Therapeutics Q4 & FY 2025 Earnings Call February 23, 2026 4:30pm ET Forward Looking Statement Any statements in this presentation about the Company's future expectations, plans and prospects, including but not limited to, statements about the clinical and preclinical development of the Company's product candidates, entry into and actions related to the Company's partnership with Akeso Inc., the Company's anticipated spending and cash runway, the therapeutic potential of the Company's product candidat ...

Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost February 23, 20268:15 PM UTCUpdated ago By Ahmed Aboulenein U.S. Food and Drug Administration Commissioner Marty Makary speaks during a press conference at the Department of Health and Human Services in Washington, D.C., U.S., November 10, 2025.... Purchase Licensing Rights, opens new tab Read ...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract. ...

FTSE 100 Index soared to a record high thanks to these stocks - Invezz# FTSE 100 Index soared to a record high thanks to these stocks[Indices]Author[Crispus Nyaga]Feb 23, 2026, 09:22 AM- Other top gainers were companies like BAE Systems, Glencore, and Weir Group.- Beazley and Schroders are the top gainers in the index.- The FTSE 100 Index continued soaring this year.The FTSE 100 Index soared to a record high last week, continuing a strong bull run that started in April when it bottomed at £4,890. It soared ...